Candriam S.C.A. Idexx Laboratories Inc Transaction History

Candriam S.C.A.

$16.8 Billion
Q2 2025

A detailed history of Candriam S.C.A. transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Candriam S.C.A. holds 79,028 shares of IDXX stock, worth $51.2 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

79,028

Previous 82,191 3.85%

Holding current value

$51.2 Million

Previous $34.5 Million 22.8%

% of portfolio

0.25%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$361.04 - $536.34 $1.14 Million - $1.7 Million	-3,163 Reduced 3.85%	79,028 $42.4 Million
Q1 2025 May 14, 2025	BUY	$406.29 - $469.04 $21.8 Million - $25.2 Million	53,647 Added 187.94%	82,191 $34.5 Million
Q4 2024 Feb 06, 2025	BUY	$406.92 - $495.42 $2.28 Million - $2.78 Million	5,610 Added 24.46%	28,544 $11.8 Million
Q3 2024 Nov 13, 2024	BUY	$455.08 - $517.19 $2.21 Million - $2.51 Million	4,850 Added 26.82%	22,934 $11.6 Million
Q2 2024 Aug 05, 2024	SELL	$468.04 - $548.53 $3.49 Million - $4.09 Million	-7,454 Reduced 29.19%	18,084 $8.81 Million
Q1 2024 May 03, 2024	SELL	$515.08 - $576.87 $4.69 Million - $5.25 Million	-9,098 Reduced 26.27%	25,538 $13.8 Million
Q4 2023 Feb 14, 2024	SELL	$391.37 - $557.56 $234,430 - $333,978	-599 Reduced 1.7%	34,636 $19.2 Million
Q3 2023 Nov 13, 2023	BUY	$432.42 - $556.67 $12.6 Million - $16.2 Million	29,154 Added 479.43%	35,235 $15.4 Million
Q2 2023 Aug 08, 2023	SELL	$450.7 - $503.61 $3.79 Million - $4.23 Million	-8,409 Reduced 58.03%	6,081 $3.05 Million
Q1 2023 May 12, 2023	SELL	$406.01 - $514.59 $913,928 - $1.16 Million	-2,251 Reduced 13.45%	14,490 $7.25 Million
Q4 2022 Feb 13, 2023	BUY	$324.64 - $441.27 $319,445 - $434,209	984 Added 6.24%	16,741 $6.83 Million
Q3 2022 Nov 10, 2022	BUY	$325.8 - $407.78 $3.13 Million - $3.92 Million	9,622 Added 156.84%	15,757 $5.13 Million
Q2 2022 Aug 03, 2022	SELL	$327.37 - $553.44 $16.6 Million - $28 Million	-50,556 Reduced 89.18%	6,135 $2.15 Million
Q1 2022 May 13, 2022	BUY	$466.52 - $631.01 $1.42 Million - $1.92 Million	3,046 Added 5.68%	56,691 $31 Million
Q4 2021 Feb 10, 2022	BUY	$586.54 - $666.48 $5.76 Million - $6.54 Million	9,819 Added 22.4%	53,645 $35.3 Million
Q3 2021 Nov 09, 2021	SELL	$621.9 - $705.76 $3.79 Million - $4.31 Million	-6,100 Reduced 12.22%	43,826 $27.3 Million
Q2 2021 Jul 20, 2021	BUY	$486.36 - $637.08 $21.2 Million - $27.8 Million	43,592 Added 688.22%	49,926 $31.5 Million
Q4 2020 Jan 22, 2021	SELL	$383.85 - $499.87 $5.23 Million - $6.81 Million	-13,622 Reduced 68.26%	6,334 $3.17 Million
Q3 2020 Oct 19, 2020	SELL	$334.54 - $406.31 $1.76 Million - $2.14 Million	-5,258 Reduced 20.85%	19,956 $7.85 Million
Q2 2020 Jul 23, 2020	BUY	$230.66 - $330.16 $4.17 Million - $5.96 Million	18,061 Added 252.5%	25,214 $8.33 Million
Q4 2019 Jan 21, 2020	BUY	$248.66 - $285.01 $337,680 - $387,043	1,358 Added 23.43%	7,153 $2,000
Q3 2019 Oct 21, 2019	SELL	$260.07 - $289.93 $98,566 - $109,883	-379 Reduced 6.14%	5,795 $2,000
Q1 2019 May 02, 2019	BUY	$178.02 - $225.69 $44,505 - $56,422	250 Added 4.22%	6,174 $1.38 Million
Q3 2018 Nov 07, 2018	BUY	$218.82 - $254.46 $63,238 - $73,538	289 Added 5.13%	5,924 $1.48 Million
Q2 2018 Aug 14, 2018	BUY	$185.56 - $227.9 $1.05 Million - $1.28 Million	5,635 New	5,635 $1.23 Million
Q1 2018 May 09, 2018	SELL	$157.81 - $204.73 $317,198 - $411,507	-2,010 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$147.68 - $168.37 $395,782 - $451,231	-2,680 Reduced 57.14%	2,010 $314,000
Q3 2017 Nov 03, 2017	BUY	$150.32 - $166.46 $705,000 - $780,697	4,690	4,690 $729,000

Others Institutions Holding IDXX

# of Institutions

1,392

Shares Held

75.4M

Call Options Held

177K

Put Options Held

226K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $53.9B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account